Oligonucleotide & ASO CDMOs — Ranked by Signal Score · 2026
43
CDMOs tracked
20
Fully scored
9
With FDA records
20
FDA inspections
37
EMA/MHRA GMP certs
Oligonucleotide CDMOs make antisense oligonucleotides (ASOs), siRNAs, and related nucleic-acid drugs by solid-phase synthesis, with downstream purification and conjugation (e.g. GalNAc). The segment has grown sharply alongside approved ASO and siRNA therapeutics.
Choosing an oligonucleotide CDMO turns on synthesis scale, chemistry breadth (phosphorothioate backbones, 2'-modifications, conjugation), purity, and a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 8 NAI (no action), 10 VAI (voluntary action), 2 OAI (official action). Leading inspection & GMP sites: United States (15), Spain (10), Italy (9), Germany (5), Belgium (4).
Last updated 2026-08-17. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
| # | CDMO | Signal Score | Quality | FDA · GMP | Capacity | Programs |
|---|---|---|---|---|---|---|
| 1 |
AL
Agilent Technologies (Oligo GMP)
Santa Clara, CA
|
74.2 | 100.0 | 2 insp · 0 GMP | — | 1 programs |
| 2 |
AX
Axolabs (Nuvisan)
Kulmbach, Germany
|
72.5 | 98.8 | 1 insp · 0 GMP | — | 3 programs |
| 3 |
AJ
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
|
85.6 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 4 |
BA
Bachem
Bubendorf, CH
|
83.5 | 98.9 | 3 insp · 0 GMP | — | 0 programs |
| 5 |
CD
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
|
82.5 | 99.7 | 4 insp · 10 GMP | — | 0 programs |
| 6 |
ND
Nitto Denko Avecia
Milford, MA
|
80.3 | 100.0 | 2 insp · 0 GMP | — | 0 programs |
| 7 |
KE
Kaneka Eurogentec
Seraing, BE
|
80.3 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 8 |
CRA
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
|
79.4 | 99.9 | 2 insp · 18 GMP | — | 0 programs |
| 9 |
SP
ST Pharm
Seoul, South Korea
|
72.8 | 88.1 | 2 insp · 4 GMP | — | 0 programs |
| 10 |
TL
TriLink BioTechnologies
San Diego, CA
|
71.0 | — | — | — | 0 programs |
| 11 |
PP
PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
|
64.8 | 70.9 | 3 insp · 0 GMP | — | 0 programs |
| 12 |
LG
LGC Biosearch Technologies
Petaluma, CA · Middleton, WI
|
63.0 | — | — | — | 0 programs |
| 13 |
SM
Sumitomo Chemical Advanced Medical
Tokyo, JP
|
63.0 | — | — | — | 0 programs |
| 14 |
AU
Aurigene Pharmaceutical Services
Hyderabad, India
|
63.0 | — | — | — | 0 programs |
| 15 |
RR
RiboBio
Guangzhou, China
|
59.0 | — | — | — | 0 programs |
| 16 |
HB
Hongene Biotech
Union City, CA (US operations); Shanghai, China (primary manufacturing)
|
56.5 | — | — | — | 0 programs |
| 17 |
BS
Bio-Synthesis Inc.
Lewisville, TX
|
56.5 | — | — | — | 0 programs |
| 18 |
CG2
ChemGenes Corporation
Wilmington, MA
|
56.5 | — | — | — | 0 programs |
| 19 |
MM
Mermade (BioAutomation)
Irving, TX
|
56.5 | — | — | — | 0 programs |
| 20 |
GR
Glen Research
Sterling, VA
|
56.5 | — | — | — | 0 programs |
| — |
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
Olon Group
Rodano (Milan), Italy
|
Profiled | — | — | — | 0 programs |
| — |
Pyramid Pharma Services (Pyramid Laboratories, Inc.)
Costa Mesa, CA
|
Profiled | — | — | — | 0 programs |
| — |
PCI Pharma Services
Philadelphia, PA
|
Profiled | — | — | — | 0 programs |
| — |
Coriolis Pharma
Martinsried (Munich), Germany
|
Profiled | — | — | — | 0 programs |
| — |
CPC Scientific
Sunnyvale, CA
|
Profiled | — | — | — | 0 programs |
| — |
Vetter Pharma International GmbH
Ravensburg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Veranova
Devens, MA
|
Profiled | — | — | — | 0 programs |
| — |
Sai Life Sciences
Hyderabad, India
|
Profiled | — | — | — | 0 programs |
| — |
EUROAPI
Paris, France
|
Profiled | — | — | — | 0 programs |
| — |
Exelead (now MilliporeSigma / Merck KGaA — Indianapolis LNP Site)
Indianapolis, IN
|
Profiled | — | — | — | 0 programs |
| — |
BioSpring GmbH
Frankfurt, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Integrated DNA Technologies (IDT)
Coralville, IA
|
Profiled | — | — | — | 0 programs |
| — |
Asymchem / AsymBio
Tianjin, China (primary manufacturing); Morrisville, NC (US HQ)
|
Profiled | — | — | — | 0 programs |
| — |
WuXi STA (Shanghai SynTheAll Pharmaceutical Co., Ltd.)
Shanghai, China
|
Profiled | — | — | — | 0 programs |
| — |
Dow Development Laboratories (DDL)
Petaluma, CA
|
Profiled | — | — | — | 0 programs |
| — |
Axplora
Raubling, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Novasep
Lyon, France
|
Profiled | — | — | — | 0 programs |
| — |
Cerbios-Pharma
Lugano, Switzerland
|
Profiled | — | — | — | 0 programs |
| — |
PeptiStar Inc.
Yamagata, Japan
|
Profiled | — | — | — | 0 programs |
| — |
Dr. Reddy's Laboratories
Hyderabad, India
|
Profiled | — | — | — | 0 programs |
| — |
Anthem Biosciences
Bengaluru, India
|
Profiled | — | 1 insp · 0 GMP | — | 0 programs |
| — |
GeneDesign, Inc. (now part of Ajinomoto Bio-Pharma Services)
Osaka, Japan
|
Profiled | — | — | — | 0 programs |
What to evaluate in a Oligonucleotide / ASO CDMO
Synthesis scale
Match synthesizer scale (mmol to mol) to your clinical and commercial demand, and confirm the CDMO can scale without shifting the impurity profile.
Chemistry & conjugation
Confirm experience with your backbone and modifications (phosphorothioate, 2'-MOE/F) and any conjugation (GalNAc, lipid) your molecule requires.
Purity & analytics
Full-length product, deletion/addition impurities, and residual metals drive release. Look for established orthogonal analytics.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
Oligonucleotide / ASO CDMOs — Frequently Asked Questions
Who are the top Oligonucleotide / ASO CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked Oligonucleotide / ASO CDMOs include Agilent Technologies (Oligo GMP), Axolabs (Nuvisan), Ajinomoto Bio-Pharma Services. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many Oligonucleotide / ASO CDMOs have FDA inspection records?
CDMO Signal tracks 9 Oligonucleotide / ASO CDMOs with FDA inspection records and 37 EMA/MHRA GMP certificates across the group.
What should I look for in an oligonucleotide CDMO?
Match synthesis scale to your demand, confirm experience with your backbone chemistry and any conjugation (e.g. GalNAc), prioritize strong purity analytics, and a clean FDA and EMA/MHRA record.
What therapeutics do oligonucleotide CDMOs make?
Antisense oligonucleotides (ASOs), siRNAs, aptamers, and related nucleic-acid drugs — increasingly with conjugation chemistries like GalNAc for targeted delivery.
Related modalities